CONMED CORPORATION Product Warranty Expense
CONMED CORPORATION (CNMD) reported Product Warranty Expense of $2.40 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-07-29.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:ProductWarrantyExpense · last filed 2026-07-29
- CONMED CORPORATION product warranty expense for the quarter ending 2025-12-31 was $1.00M, a 9.09% decline year-over-year.
- CONMED CORPORATION product warranty expense for the quarter ending 2025-09-30 was $1.00M, a 16.67% decline year-over-year.
- CONMED CORPORATION product warranty expense for the quarter ending 2025-06-30 was $1.20M, a 7.69% decline year-over-year.
- CONMED CORPORATION product warranty expense for the quarter ending 2025-03-31 was $1.00M, a 23.08% decline year-over-year.
- CONMED CORPORATION product warranty expense for fiscal 2025 was $4.20M, a 14.29% decline from fiscal 2024.
- CONMED CORPORATION product warranty expense for fiscal 2024 was $4.90M, a 2.08% increase from fiscal 2023.
- CONMED CORPORATION product warranty expense for fiscal 2023 was $4.80M, a 18.64% decline from fiscal 2022.
- CONMED CORPORATION product warranty expense for fiscal 2022 was $5.90M, a 13.24% decline from fiscal 2021.
| Period end | Product Warranty Expense 3 month | Product Warranty Expense 6 month | Product Warranty Expense 9 month | Product Warranty Expense 12 month |
|---|---|---|---|---|
| 2026-06-30 | $2.40M 10-Q · filed 2026-07-29 | |||
| 2025-12-31 | $1.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-17 | $2.00M derived: sum of 2 quarters · filed 2026-02-17 | $3.20M derived: sum of 3 quarters · filed 2026-07-29 | $4.20M 10-K · filed 2026-02-17 |
| 2025-09-30 | $1.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | $2.20M derived: sum of 2 quarters · filed 2026-07-29 | $3.20M 10-Q · filed 2025-11-06 | $4.30M derived: sum of 4 quarters · filed 2026-07-29 |
| 2025-06-30 | $1.20M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-29 | $2.20M 10-Q · filed 2026-07-29 | $3.30M derived: sum of 3 quarters · filed 2026-07-29 | $4.50M derived: sum of 4 quarters · filed 2026-07-29 |
| 2025-03-31 | $1.00M 10-Q · filed 2025-05-01 | $2.10M derived: sum of 2 quarters · filed 2026-02-17 | $3.30M derived: sum of 3 quarters · filed 2026-02-17 | $4.60M derived: sum of 4 quarters · filed 2026-02-17 |
| 2024-12-31 | $1.10M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-17 | $2.30M derived: sum of 2 quarters · filed 2026-02-17 | $3.60M derived: sum of 3 quarters · filed 2026-02-17 | $4.90M 10-K · filed 2026-02-17 |
| 2024-09-30 | $1.20M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | $2.50M derived: sum of 2 quarters · filed 2025-11-06 | $3.80M 10-Q · filed 2025-11-06 | $4.70M derived: sum of 4 quarters · filed 2026-02-17 |
| 2024-06-30 | $1.30M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-07-31 | $2.60M 10-Q · filed 2025-07-31 | $3.50M derived: sum of 3 quarters · filed 2026-02-17 | $4.80M derived: sum of 4 quarters · filed 2026-02-17 |
| 2024-03-31 | $1.30M 10-Q · filed 2025-05-01 | $2.20M derived: sum of 2 quarters · filed 2026-02-17 | $3.50M derived: sum of 3 quarters · filed 2026-02-17 | $4.60M derived: sum of 4 quarters · filed 2026-02-17 |
| 2023-12-31 | $900.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-17 | $2.20M derived: sum of 2 quarters · filed 2026-02-17 | $3.30M derived: sum of 3 quarters · filed 2026-02-17 | $4.80M 10-K · filed 2026-02-17 |
| 2023-09-30 | $1.30M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-10-31 | $2.40M derived: sum of 2 quarters · filed 2024-10-31 | $3.90M 10-Q · filed 2024-10-31 | $5.20M derived: sum of 4 quarters · filed 2025-02-18 |
| 2023-06-30 | $1.10M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-01 | $2.60M 10-Q · filed 2024-08-01 | $3.90M derived: sum of 3 quarters · filed 2025-02-18 | $5.30M derived: sum of 4 quarters · filed 2025-02-18 |
| 2023-03-31 | $1.50M 10-Q · filed 2024-04-25 | $2.80M derived: sum of 2 quarters · filed 2025-02-18 | $4.20M derived: sum of 3 quarters · filed 2025-02-18 | $5.80M derived: sum of 4 quarters · filed 2025-02-18 |
| 2022-12-31 | $1.30M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-18 | $2.70M derived: sum of 2 quarters · filed 2025-02-18 | $4.30M derived: sum of 3 quarters · filed 2025-02-18 | $5.90M 10-K · filed 2025-02-18 |
| 2022-09-30 | $1.40M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-10-26 | $3.00M derived: sum of 2 quarters · filed 2023-10-26 | $4.60M 10-Q · filed 2023-10-26 | $6.20M derived: sum of 4 quarters · filed 2024-02-28 |
| 2022-06-30 | $1.60M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-07-27 | $3.20M 10-Q · filed 2023-07-27 | $4.80M derived: sum of 3 quarters · filed 2024-02-28 | $6.60M derived: sum of 4 quarters · filed 2024-02-28 |
| 2022-03-31 | $1.60M 10-Q · filed 2023-04-27 | $3.20M derived: sum of 2 quarters · filed 2024-02-28 | $5.00M derived: sum of 3 quarters · filed 2024-02-28 | $6.80M derived: sum of 4 quarters · filed 2024-02-28 |
| 2021-12-31 | $1.60M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-28 | $3.40M derived: sum of 2 quarters · filed 2024-02-28 | $5.20M derived: sum of 3 quarters · filed 2024-02-28 | $6.80M 10-K · filed 2024-02-28 |
| 2021-09-30 | $1.80M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-10-27 | $3.60M derived: sum of 2 quarters · filed 2022-10-27 | $5.20M 10-Q · filed 2022-10-27 | $6.90M derived: sum of 4 quarters · filed 2023-02-21 |
| 2021-06-30 | $1.80M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-07-28 | $3.40M 10-Q · filed 2022-07-28 | $5.10M derived: sum of 3 quarters · filed 2023-02-21 | $6.50M derived: sum of 4 quarters · filed 2023-02-21 |
| 2021-03-31 | $1.60M 10-Q · filed 2021-04-29 | $3.30M derived: sum of 2 quarters · filed 2023-02-21 | $4.70M derived: sum of 3 quarters · filed 2023-02-21 | $6.20M derived: sum of 4 quarters · filed 2023-02-21 |
| 2020-12-31 | $1.70M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-21 | $3.10M derived: sum of 2 quarters · filed 2023-02-21 | $4.60M derived: sum of 3 quarters · filed 2023-02-21 | $6.10M 10-K · filed 2023-02-21 |
| 2020-09-30 | $1.40M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-10-28 | $2.90M derived: sum of 2 quarters · filed 2021-10-28 | $4.40M 10-Q · filed 2021-10-28 | $5.70M derived: sum of 4 quarters · filed 2022-02-22 |
| 2020-06-30 | $1.50M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-07-29 | $3.00M 10-Q · filed 2021-07-29 | $4.30M derived: sum of 3 quarters · filed 2022-02-22 | $5.50M derived: sum of 4 quarters · filed 2022-02-22 |
| 2020-03-31 | $1.50M 10-Q · filed 2021-04-29 | $2.80M derived: sum of 2 quarters · filed 2022-02-22 | $4.00M derived: sum of 3 quarters · filed 2022-02-22 | $5.40M derived: sum of 4 quarters · filed 2022-02-22 |
| 2019-12-31 | $1.30M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-22 | $2.50M derived: sum of 2 quarters · filed 2022-02-22 | $3.90M derived: sum of 3 quarters · filed 2022-02-22 | $5.30M 10-K · filed 2022-02-22 |
| 2019-09-30 | $1.20M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-10-29 | $2.60M derived: sum of 2 quarters · filed 2020-10-29 | $4.00M 10-Q · filed 2020-10-29 | $4.90M derived: sum of 4 quarters · filed 2021-02-22 |
| 2019-06-30 | $1.40M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-07-30 | $2.80M 10-Q · filed 2020-07-30 | $3.70M derived: sum of 3 quarters · filed 2021-02-22 | $5.30M derived: sum of 4 quarters · filed 2021-02-22 |
| 2019-03-31 | $1.40M 10-Q · filed 2020-04-30 | $2.30M derived: sum of 2 quarters · filed 2021-02-22 | $3.90M derived: sum of 3 quarters · filed 2021-02-22 | $5.00M derived: sum of 4 quarters · filed 2021-02-22 |
| 2018-12-31 | $900.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-22 | $2.50M derived: sum of 2 quarters · filed 2021-02-22 | $3.60M derived: sum of 3 quarters · filed 2021-02-22 | $4.90M 10-K · filed 2021-02-22 |
| 2018-09-30 | $1.60M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-10-31 | $2.70M derived: sum of 2 quarters · filed 2019-10-31 | $4.00M 10-Q · filed 2019-10-31 | $5.80M derived: sum of 4 quarters · filed 2020-02-24 |
| 2018-06-30 | $1.10M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-01 | $2.40M 10-Q · filed 2019-08-01 | $4.20M derived: sum of 3 quarters · filed 2020-02-24 | $4.80M derived: sum of 4 quarters · filed 2020-02-24 |
| 2018-03-31 | $1.30M 10-Q · filed 2019-04-26 | $3.10M derived: sum of 2 quarters · filed 2020-02-24 | $3.70M derived: sum of 3 quarters · filed 2020-02-24 | $4.80M derived: sum of 4 quarters · filed 2020-02-24 |
| 2017-12-31 | $1.80M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-24 | $2.40M derived: sum of 2 quarters · filed 2020-02-24 | $3.50M derived: sum of 3 quarters · filed 2020-02-24 | $4.60M 10-K · filed 2020-02-24 |
| 2017-09-30 | $600.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-02 | $1.70M derived: sum of 2 quarters · filed 2018-11-02 | $2.80M 10-Q · filed 2018-11-02 | |
| 2017-06-30 | $1.10M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-02 | $2.20M 10-Q · filed 2018-08-02 | ||
| 2017-03-31 | $1.10M 10-Q · filed 2018-04-26 | |||
| 2016-12-31 | $4.10M 10-K · filed 2019-02-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Ceribell, Inc. (CBLL) | United States | $0.916B | -11.27 |
| BIOLIFE SOLUTIONS INC (BLFS) | United States | $1.887B | 23.80 |
| Axogen, Inc. (AXGN) | United States | $2.329B | -73.83 |
| CapsoVision, Inc (CV) | United States | $0.310B | -12.68 |
| Electromed, Inc. (ELMD) | United States | $0.233B | 31.13 |
| EDAP TMS SA (FOCL) | $0.171B | ||
| Stereotaxis, Inc. (STXS) | United States | $0.130B | -7.53 |
| Vivani Medical, Inc. (VANI) | United States | $0.111B | |
| electroCore, Inc. (ECOR) | United States | $0.102B | |
| Neuraxis, INC (NRXS) | United States | $0.097B |